Is Getting a Hollywood Smile Worth It?
If you have been diagnosed with migraines and suffer from constant headaches, you might ask if there’s something you can do to prevent them. Botox is the answer. Because botox was approved as a treatment of migraines in 2010 for adults who suffer from chronic migraines.
What is Migraine?
First of all, for those who are unfamiliar with migraines, they are not the same as headaches. Headaches are painful too, but they’re generally less severe than migraines and don’t come with any other symptoms apart from the pain and aching in the head. On the other hand, migraines are also accompanied by nausea, seeing spots, vomiting, excessive fatigue, sensitivity to light and sound, and other symptoms.
What’s the Difference Between Migraine Botox and Cosmetic Botox?
Undoubtedly, botox that is used as a treatment of migraines and for cosmetic procedures is the same thing. Women are particularly affected by migraines, accounting for almost 85 percent of chronic migraine sufferers. Hence, doctors started looking into Botox as a direct remedy after women who had it for cosmetic purposes noticed relief from their migraine symptoms.
How Botox Effects the Migraine Pain?
In chronic migraines, sensory nerves become inflamed and hypersensitive. Meanwhile, botox acts as a pain reliever by preventing the communication of nerves.
Migraine Injection Areas for Botox
Specifically, the treatment of migraines consists of 31 injections of 5 units each. The following locations are likely to be used as injection sites:
- The upper bridge above the nose
- Forehead
- Temples
- Back of the head
- Neck
- Upper back
What are The Predicted Botox Treatment Benefits?
- More than 50% reduction is observed in the frequency and severity of migraines. As a result, if you have migraine pain for 20 days a month, it may decrease to ten days.
- About half of the patients in the studies achieved this goal after six months of treatment.
- Some people progress faster than others. In studies, a 75% reduction in migraine pain was observed in 23% of patients. Also, it was observed that people who experienced pain for 20 days experienced migraine pain for up to 5 days.
References:
- Frampton JE, Silberstein S. OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine. Drugs. 2018;78(5):589-600.
- Ashkenazi A, Blumenfeld A. OnabotulinumtoxinA for the treatment of headache. Headache. 2013;53 Suppl 2:54-61.
Comments(0)